Exhaled eicosanoids following oral aspirin challenge in asthmatic patients
about
sameAs
Aspirin-exacerbated asthma.Elevation of Eosinophil-Derived Neurotoxin in Plasma of the Subjects with Aspirin-Exacerbated Respiratory Disease: A Possible Peripheral Blood Protein Biomarker.Variants of CEP68 gene are associated with acute urticaria/angioedema induced by multiple non-steroidal anti-inflammatory drugsDiagnostic value of clinical parameters in the prediction of aspirin-exacerbated respiratory disease in asthma.Exhaled breath condensate in patients with asthma: implications for application in clinical practice.Aspirin-intolerant asthma: a comprehensive review of biomarkers and pathophysiology.Exhaled Eicosanoids following Bronchial Aspirin Challenge in Asthma Patients with and without Aspirin Hypersensitivity: The Pilot Study.Development of a genetic marker set to diagnose aspirin-exacerbated respiratory disease in a genome-wide association study.Pathogenic Mechanisms and In Vitro Diagnosis of AERD.Genetic variants of the arachidonic acid pathway in non-steroidal anti-inflammatory drug-induced acute urticaria.Genome-wide association study in NSAID-induced acute urticaria/angioedema in Spanish and Han Chinese populations.Metabolomic analysis identifies potential diagnostic biomarkers for aspirin-exacerbated respiratory disease.Induced sputum eicosanoids during aspirin bronchial challenge of asthmatic patients with aspirin hypersensitivity.
P2860
Q33846722-F2299333-7F72-4A3F-AC38-4425F1FBCD2AQ34785484-7BA729AD-868A-4CD8-81FA-60C2BCDFAC44Q35117697-5BDEF35F-BB8E-40F1-9E72-7D1E3777CEAFQ35228588-56C16DDC-AED8-46EB-8782-4008A1369EB3Q37114066-7082BBB6-1AA8-4BB8-9539-A8A7BC833398Q38062847-721C2F0A-486E-446B-841E-3BB1F3A284E2Q40629569-3B6E525D-3359-428D-B5AA-4360619FD5F1Q41365516-6364103E-E2C7-480D-B4A2-4EBFF5ECD894Q41898865-83FFAFE7-D137-4E95-9DCB-746386B62DC9Q43528905-D98B6334-8D58-4E29-A649-E1EF85AF27EDQ44390657-A2E2A33E-C765-4AE0-A2FA-A29989396E75Q51469727-CA5EF6AB-3F07-4FF7-8A2E-634BCACC095FQ51703960-F8549784-E5FB-485A-A2CA-5FD9F0AB76FD
P2860
Exhaled eicosanoids following oral aspirin challenge in asthmatic patients
description
2004 nî lūn-bûn
@nan
2004 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Exhaled eicosanoids following oral aspirin challenge in asthmatic patients
@ast
Exhaled eicosanoids following oral aspirin challenge in asthmatic patients
@en
Exhaled eicosanoids following oral aspirin challenge in asthmatic patients
@nl
type
label
Exhaled eicosanoids following oral aspirin challenge in asthmatic patients
@ast
Exhaled eicosanoids following oral aspirin challenge in asthmatic patients
@en
Exhaled eicosanoids following oral aspirin challenge in asthmatic patients
@nl
prefLabel
Exhaled eicosanoids following oral aspirin challenge in asthmatic patients
@ast
Exhaled eicosanoids following oral aspirin challenge in asthmatic patients
@en
Exhaled eicosanoids following oral aspirin challenge in asthmatic patients
@nl
P2860
P1476
Exhaled eicosanoids following oral aspirin challenge in asthmatic patients
@en
P2093
B Kiełbasa
G Bochenek
P2860
P304
P356
10.1111/J.1365-2222.2004.02123.X
P407
P577
2004-12-01T00:00:00Z